dexmedetomidine has been researched along with Schizophrenia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Citrome, L; Rajachandran, L; Risinger, R; Robison, H | 1 |
| Citrome, L; De Vivo, M; Finman, J; Kakar, R; Krystal, JH; Lauriello, J; Preskorn, SH; Rajachandran, L; Risinger, R; Yocca, FD | 1 |
| Citrome, L; Faden, J; Musselman, M | 1 |
| Hirota, K; Kubota, M; Saito, J; Takekawa, D | 1 |
| Citrome, L; Ward, K | 1 |
1 review(s) available for dexmedetomidine and Schizophrenia
| Article | Year |
|---|---|
The treatment of acute agitation associated with schizophrenia or bipolar disorder: investigational drugs in early stages of their clinical development, and their clinical context and potential place in therapy.
Topics: Aggression; Antipsychotic Agents; Bipolar Disorder; Dexmedetomidine; Drug Development; Drugs, Investigational; Humans; Olanzapine; Psychomotor Agitation; Schizophrenia | 2020 |
2 trial(s) available for dexmedetomidine and Schizophrenia
| Article | Year |
|---|---|
Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Dexmedetomidine; Double-Blind Method; Humans; Schizophrenia; Treatment Outcome | 2022 |
Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial.
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Antipsychotic Agents; Dexmedetomidine; Double-Blind Method; Humans; Male; Middle Aged; Psychotic Disorders; Schizophrenia; Sleepiness; Treatment Outcome | 2022 |
2 other study(ies) available for dexmedetomidine and Schizophrenia
| Article | Year |
|---|---|
Sublingual dexmedetomidine: repurposing an anesthetic as an anti-agitation agent.
Topics: Adult; Anesthetics; Antipsychotic Agents; Dexmedetomidine; Humans; Psychomotor Agitation; Schizophrenia | 2023 |
Postoperative Dexmedetomidine-Induced Polyuria in a Patient With Schizophrenia: A Case Report.
Topics: Aged; Dexmedetomidine; Humans; Infusions, Intravenous; Male; Monitoring, Physiologic; Parotid Gland; Polyuria; Postoperative Complications; Schizophrenia; Sodium | 2020 |